Martin Stockler
Martin Stockler
NHMRC Clinical Trials Centre, University of Sydney
Verified email at - Homepage
Cited by
Cited by
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
IF Tannock, D Osoba, MR Stockler, DS Ernst, AJ Neville, MJ Moore, ...
Journal of clinical oncology 14 (6), 1756-1764, 1996
Enzalutamide with standard first-line therapy in metastatic prostate cancer
ID Davis, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ...
New England Journal of Medicine 381 (2), 121-131, 2019
[177Lu] Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
MS Hofman, L Emmett, S Sandhu, A Iravani, AM Joshua, JC Goh, ...
The Lancet 397 (10276), 797-804, 2021
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III …
NC Tebbutt, K Wilson, VJ Gebski, MM Cummins, D Zannino, ...
Journal of clinical oncology 28 (19), 3191-3198, 2010
Bisphosphonates for breast cancer
N Pavlakis, RL Schmidt, MR Stockler
Cochrane Database of Systematic Reviews, 2005
Bisphosphonates and other bone agents for breast cancer
B O'Carrigan, MHF Wong, ML Willson, MR Stockler, N Pavlakis, ...
Cochrane database of systematic reviews, 2017
The importance of patient-reported outcomes in clinical trials and strategies for future optimization
R Mercieca-Bebber, MT King, MJ Calvert, MR Stockler, M Friedlander
Patient related outcome measures, 353-367, 2018
Duration of chemotherapy for advanced non–small-cell lung cancer: a systematic review and meta-analysis of randomized trials
YY Soon, MR Stockler, LM Askie, MJ Boyer
Journal of clinical oncology 27 (20), 3277-3283, 2009
Duration of chemotherapy for metastatic breast cancer: a systematic review and meta-analysis of randomized clinical trials
A Gennari, M Stockler, M Puntoni, M Sormani, O Nanni, D Amadori, ...
Journal of clinical oncology 29 (16), 2144-2149, 2011
Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer
M Stockler, NRC Wilcken, D Ghersi, RJ Simes
Cancer treatment reviews 26 (3), 151-168, 2000
Third consensus on medical treatment of metastatic breast cancer
S Beslija, J Bonneterre, HJ Burstein, V Cocquyt, M Gnant, V Heinemann, ...
Annals of oncology 20 (11), 1771-1785, 2009
Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 …
GM Duchesne, HH Woo, JK Bassett, SJ Bowe, C D'Este, M Frydenberg, ...
The Lancet Oncology 17 (6), 727-737, 2016
Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer
MR Stockler, F Hilpert, M Friedlander, MT King, L Wenzel, CK Lee, F Joly, ...
Journal of Clinical Oncology 32 (13), 1309-1316, 2014
Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer
P Glare, G Pereira, LJ Kristjanson, M Stockler, M Tattersall
Supportive Care in Cancer 12, 432-440, 2004
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 …
D Stark, M Nankivell, E Pujade-Lauraine, G Kristensen, L Elit, M Stockler, ...
The lancet oncology 14 (3), 236-243, 2013
Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer
MR Stockler, VJ Harvey, PA Francis, MJ Byrne, SP Ackland, B Fitzharris, ...
Journal of clinical oncology 29 (34), 4498-4504, 2011
Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review
CA Hauser, MR Stockler, MHN Tattersall
Supportive Care in Cancer 14, 999-1011, 2006
Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial
MR Stockler, R O'Connell, AK Nowak, D Goldstein, J Turner, ...
The lancet oncology 8 (7), 603-612, 2007
Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo …
M Stockler, J Vardy, A Pillai, D Warr
Journal of clinical oncology 22 (16), 3389-3394, 2004
Bisphosphonates for breast cancer.
N Pavlakis, M Stockler
The Cochrane database of systematic reviews, CD003474-CD003474, 2002
The system can't perform the operation now. Try again later.
Articles 1–20